{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:23:43Z","timestamp":1790267023709,"version":"4.1.0"},"reference-count":327,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Johnson &amp; Johnson Innovative Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>This study presents and discusses evidence on the value of biomarker testing and precision medicine in Latin America through a health equity lens. It is essential to explore how to harness the benefits of precision medicine to narrow the health equity gap, ensuring all patients have access to the best cancer treatment. The methodology employed to develop this document consists of a non-systematic literature review, followed by a process of validation and feedback with a group of experts in relevant fields. Precision medicine could help reduce health inequities in Latin America by providing better diagnosis and treatment for everyone with cancer. However, its success in achieving this depends on the implementation of policies that promote equitable access. Findings indicate that the current policy landscape in the Latin American region is not conducive to improving access, reach, quality, or outcome-related problems in cancer care, nor to realizing the full potential of precision medicine. The study explores how precision medicine can advance health equity, concluding with an analysis of the challenges and recommendations for overcoming them.<\/jats:p>","DOI":"10.3390\/ijerph22081220","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:44:32Z","timestamp":1754401472000},"page":"1220","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping"],"prefix":"10.3390","volume":"22","author":[{"given":"Ana Rita","family":"Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizbeth Alexandra Acu\u00f1a","family":"Merch\u00e1n","sequence":"additional","affiliation":[{"name":"Cuenta de Alto Costo, Cra. 45 #103 34 Oficina 802, Bogot\u00e1 110111, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A. Alatorre","family":"Alexander","sequence":"additional","affiliation":[{"name":"Health Pharma Professional Research S.A de C.V., Av. Insurgentes Sur 662-Piso 3, Col. Del Valle, Benito Ju\u00e1rez, Ciudad de M\u00e9xico 03100, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-0164","authenticated-orcid":false,"given":"Diego","family":"Kaen","sequence":"additional","affiliation":[{"name":"Centro Oncologico Riojano Integral, La Rioja F5300, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Lopez-Correa","sequence":"additional","affiliation":[{"name":"Genome Canada, 50 Metcalfe Street, Suite 2100, Ottawa, ON K2P 1P1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Martin","sequence":"additional","affiliation":[{"name":"Alexander Fleming Institute, Av. Cr\u00e1mer 1180\u2014C1426ANZ, Buenos Aires C1426, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-983X","authenticated-orcid":false,"given":"Allira","family":"Attwill","sequence":"additional","affiliation":[{"name":"Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Marinetti","sequence":"additional","affiliation":[{"name":"Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor","family":"Rocha","sequence":"additional","affiliation":[{"name":"Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-667X","authenticated-orcid":false,"given":"Carlos","family":"Barrios","sequence":"additional","affiliation":[{"name":"LACOG\u2014Latin American Cooperative Oncology Group, Porto Alegre 91900-580, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"ref_1","unstructured":"Mount Sinai (2024, July 08). Targeted Therapies for Cancer. Available online: https:\/\/www.mountsinai.org\/health-library\/special-topic\/targeted-therapies-for-cancer."},{"key":"ref_2","unstructured":"National Library of Medicine (2024, April 01). What Is Precision Medicine?, Available online: https:\/\/medlineplus.gov\/genetics\/understanding\/precisionmedicine\/definition\/."},{"key":"ref_3","unstructured":"National Cancer Institute (2025, July 14). Biomarker Testing, Available online: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/biomarker-testing."},{"key":"ref_4","unstructured":"National Cancer Institute (2025, July 14). Targeted Therapy to Treat Cancer, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies."},{"key":"ref_5","unstructured":"World Health Organization (2024, June 13). Health Technologies. Available online: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/health-technologies."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/br.2017.922","article-title":"Personalized medicine could transform healthcare","volume":"7","author":"Mathur","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_7","unstructured":"CSDH (2024, July 20). Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Final Report of the Commission on Social Determinants of Health. Geneva. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/43943\/9789241563703_eng.pdf."},{"key":"ref_8","unstructured":"World Health Organization (2024, April 16). Health Equity. Available online: https:\/\/www.who.int\/health-topics\/health-equity."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nature Medicine (2021). Precision medicine needs an equity agenda. Nat. Med., 27, 737.","DOI":"10.1038\/s41591-021-01373-y"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.gim.2022.04.009","article-title":"Health equity in the implementation of genomics and precision medicine: A public health imperative","volume":"24","author":"Khoury","year":"2022","journal-title":"Genet. Med."},{"key":"ref_11","unstructured":"International Agency for Research on Cancer (2024, August 15). Global Cancer Observatory\u2014United States of America. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/840-united-states-of-america-fact-sheet.pdf."},{"key":"ref_12","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014World. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/900-world-fact-sheet.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Cort\u00e9s, A., Guerrero, S., Redal, M., Alvarado, A., and Qui\u00f1ones, L. (2017). State of Art of Cancer Pharmacogenomics in Latin American Populations. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18060639"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/cncr.30549","article-title":"Improving access to high-cost cancer drugs in Latin America: Much to be done","volume":"123","author":"Ruiz","year":"2017","journal-title":"Cancer"},{"key":"ref_15","unstructured":"Organization for Economic Co-Operation and Development (2023). Health at a Glance: Latin America and the Caribbean 2023, OECD."},{"key":"ref_16","unstructured":"World Health Organization (2024, April 10). Cancer Fact Sheet. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_17","first-page":"100294","article-title":"An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean","volume":"13","author":"Laversanne","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"ref_18","unstructured":"Sarfati, D. (2019). Why Social Inequalities Matter in the Cancer Continuum, IARC Scientific Publications."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102402","DOI":"10.1016\/j.canep.2023.102402","article-title":"Latin America and the Caribbean Code Against Cancer 1st Edition: 17 cancer prevention recommendations to the public and to policy-makers (World Code Against Cancer Framework)","volume":"86","author":"Espina","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"ref_20","unstructured":"Social Development Division of the Economic Commission for Latin America and the Caribbean (2024, April 15). Social Panorama of Latin America and the Caribbean 2023: Labour Inclusion as a Key Axis of Inclusive Social Development. Available online: https:\/\/hdl.handle.net\/11362\/68703."},{"key":"ref_21","unstructured":"World Bank (2024, May 23). Poverty Headcount Ratio at National Poverty Lines (% of Population)\u2014Argentina, Brazil, Colombia, Mexico, Panama. Available online: https:\/\/data.worldbank.org\/indicator\/SI.POV.NAHC?locations=AR-BR-CO-MX-PA."},{"key":"ref_22","unstructured":"Ag\u00eancia IBGE (2024, May 23). Poverty Drops to 31.6% of the Population in 2022, After Reaching 36.7% in 2021, Available online: https:\/\/agenciadenoticias.ibge.gov.br\/en\/agencia-news\/2184-news-agency\/news\/38574-poverty-drops-to-31-6-of-the-population-in-2022-after-reaching-36-7-in-2021."},{"key":"ref_23","unstructured":"Global Burden of Disease Collaborative Network (2024, February 29). Global Burden of Disease Study 2019 (GBD 2019) Results. [Database]. Institute for Health Metrics and Evaluation (IHME). Available online: https:\/\/vizhub.healthdata.org\/gbd-results\/."},{"key":"ref_24","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014Latin America and the Caribbean. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/904-latin-america-and-the-caribbean-fact-sheet.pdf."},{"key":"ref_25","unstructured":"United Nations (2024, June 19). Revision of World Population Prospects. Department of Economic and Social Affairs. Population Division. Available online: https:\/\/population.un.org\/wpp\/."},{"key":"ref_26","unstructured":"World Health Organization (2025, July 31). Cancer Tomorrow: Estimated Number of New Cases from 2022 to 2050, Incidence, Both Sexes, Age [0\u201385+]. Available online: https:\/\/gco.iarc.who.int\/tomorrow\/en\/dataviz\/tables?mode=population&years=2050."},{"key":"ref_27","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014Argentina. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/32-argentina-fact-sheet.pdf."},{"key":"ref_28","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014Brazil. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/76-brazil-fact-sheet.pdf."},{"key":"ref_29","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014Colombia. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/170-colombia-fact-sheet.pdf."},{"key":"ref_30","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014Mexico. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/484-mexico-fact-sheet.pdf."},{"key":"ref_31","unstructured":"International Agency for Research on Cancer (2024, February 29). Global Cancer Observatory\u2014Panama. Cancer Today. [Fact Sheet]. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/591-panama-fact-sheet.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S1470-2045(21)00492-7","article-title":"Cancer control in Latin America and the Caribbean: Recent advances and opportunities to move forward","volume":"22","author":"Barrios","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e000285","DOI":"10.1136\/esmoopen-2017-000285","article-title":"Global cancer control: Responding to the growing burden, rising costs and inequalities in access","volume":"3","author":"Prager","year":"2018","journal-title":"ESMO Open"},{"key":"ref_34","unstructured":"Worldometer (2024, February 29). GDP per Capita. Available online: https:\/\/www.worldometers.info\/gdp\/gdp-per-capita\/."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ries, L., Trama, A., Nakata, K., Gatta, G., Botta, L., and Bleyer, A. (2017). Cancer Incidence, Survival, and Mortality Among Adolescents and Young Adults, Springer.","DOI":"10.1007\/978-3-319-33679-4_2"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/jnci\/djaa007","article-title":"International Trends in the Incidence of Cancer Among Adolescents and Young Adults","volume":"112","author":"Gupta","year":"2020","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ip.6.3.177","article-title":"Cost of illness studies: What is good about them?","volume":"6","author":"Rice","year":"2000","journal-title":"Inj. Prev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Marmot, M., and Wilkinson, R. (2005). Social Determinants of Health, Oxford University Press.","DOI":"10.1093\/acprof:oso\/9780198565895.001.0001"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijchp.2015.07.005","article-title":"Psychological treatments to improve quality of life in cancer contexts: A meta-analysis","volume":"16","author":"Gambara","year":"2016","journal-title":"Int. J. Clin. Health Psychol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijchp.2017.11.002","article-title":"Quality of life in breast cancer patients: Associations with optimism and social support","volume":"18","author":"Finck","year":"2018","journal-title":"Int. J. Clin. Health Psychol."},{"key":"ref_42","first-page":"15","article-title":"Utility and health-related quality of life measures in adult Colombian patients with solid tumours","volume":"3","author":"Ocampo","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Santos MN dos, Brito RG de (2022). Qualidade de vida em pacientes com diagn\u00f3stico de c\u00e2ncer no Brasil: Uma revis\u00e3o sistem\u00e1tica. Res. Soc. Dev., 19, e28511830635.","DOI":"10.33448\/rsd-v11i8.30635"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7705\/biomedica.4971","article-title":"Calidad de vida en mujeres con c\u00e1ncer de mama sometidas a quimioterapia en Cali, Colombia","volume":"40","year":"2020","journal-title":"Biom\u00e9dica"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gonzalez, L., Bardach, A., Palacios, A., Peckaitis, C., Ciapponi, A., Pich\u00f3n-Riviere, A., and Augustovski, F. (2021). Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis. Oncologist, 26.","DOI":"10.1002\/onco.13709"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S2007-4085(15)30027-6","article-title":"Calidad de vida en pacientes con c\u00e1ncer de pr\u00f3stata, operados de prostatectom\u00eda radical laparosc\u00f3pica","volume":"74","year":"2014","journal-title":"Rev. Mex. Urol."},{"key":"ref_47","first-page":"53","article-title":"Quality of life in Mexican colorectal cancer patients: Analysis with sociodemographic, medical, and psychological variables","volume":"26","year":"2021","journal-title":"Psychol Health Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Guerra-Mart\u00edn, M.D., Casado-Espinosa, M.D.R., Gavira-L\u00f3pez, Y., Holgado-Castro, C., L\u00f3pez-Latorre, I., and Borrallo-Riego, \u00c1. (2023). Quality of Life in Caregivers of Cancer Patients: A Literature Review. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20021570"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s11864-022-00955-3","article-title":"Understanding and Supporting Informal Cancer Caregivers","volume":"23","author":"Molassiotis","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Espinola, N., Pichon-Riviere, A., Casarini, A., Alcaraz, A., Bardach, A., Williams, C., Cairoli, F.R., Augustovski, F., and Palacios, A. (2023). Making visible the cost of informal caregivers\u2019 time in Latin America: A case study for major cardiovascular, cancer and respiratory diseases in eight countries. BMC Public Health, 23.","DOI":"10.1186\/s12889-022-14835-w"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Xiang, E., Guzman, P., Mims, M., and Badr, H. (2022). Balancing Work and Cancer Care: Challenges Faced by Employed Informal Caregivers. Cancers, 14.","DOI":"10.3390\/cancers14174146"},{"key":"ref_52","unstructured":"United Nations Economic Commission for Europe (2024, June 15). Supporting Informal Carers\u2014Six Policy Challenges and How to Meet Them. Available online: https:\/\/unece.org\/population\/news\/supporting-informal-carers-six-policy-challenges-and-how-meet-them."},{"key":"ref_53","unstructured":"World Health Organization (2024, August 16). WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240001299."},{"key":"ref_54","first-page":"100559","article-title":"A fresh perspective on Latin America cancer care: Uncovering hidden messages in unconventional data sources","volume":"24","author":"Llera","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"de Lemos, L.L.P., Carvalho de Souza, M., Pena Moreira, D., Ribeiro Fernandes Almeida, P.H., Godman, B., Verguet, S., Junior, A.A.G., and Cherchiglia, M.L. (2019). Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224012"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.32749","article-title":"Cancer mortality predictions for 2019 in Latin America","volume":"147","author":"Carioli","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.1634\/theoncologist.2019-0057","article-title":"Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review","volume":"24","author":"Brand","year":"2019","journal-title":"Oncologist"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5306\/wjco.v5.i3.465","article-title":"Challenges to the early diagnosis and treatment of breast cancer in developing countries","volume":"5","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/S1470-2045(21)00523-4","article-title":"Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean","volume":"22","author":"Werutsky","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1200\/EDBK_201315","article-title":"Breast Cancer in Latin America: A Map of the Disease in the Region","volume":"38","author":"Cazap","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10549-020-05831-y","article-title":"The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)","volume":"183","author":"Rosa","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_62","first-page":"174550652094941","article-title":"Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage","volume":"16","year":"2020","journal-title":"Women\u2019s Health"},{"key":"ref_63","first-page":"100646","article-title":"Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC\u2014RELANCE\/LACOG 0118","volume":"5","author":"Gelatti","year":"2024","journal-title":"JTO Clin. Res. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Nuche-Berenguer, B., and Sakellariou, D. (2019). Socioeconomic determinants of cancer screening utilisation in Latin America: A systematic review. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225667"},{"key":"ref_65","first-page":"18","article-title":"Implementing precision oncology in Latin America to improve patient outcomes: The status quo and a call to action for key stakeholders and decision-makers","volume":"8","author":"Mayrides","year":"2024","journal-title":"Ecancermedicalscience"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40545-018-0153-y","article-title":"Access to innovative cancer medicines in a middle-income country\u2014The case of Mexico","volume":"11","author":"Reijneveld","year":"2018","journal-title":"J. Pharm. Policy Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12939-019-0960-z","article-title":"Judicialization of access to medicines in four Latin American countries: A comparative qualitative analysis","volume":"18","author":"Rover","year":"2019","journal-title":"Int. J. Equity Health"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chagas, V.O., Provin, M.P., Mota, P.A.P., Guimar\u00e3es, R.A., and Amaral, R.G. (2020). Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil. BMC Health Serv. Res., 20.","DOI":"10.1186\/s12913-020-4929-9"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12939-019-0961-y","article-title":"Is the judicialization of health care bad for equity? A scoping review","volume":"18","author":"Andia","year":"2019","journal-title":"Int. J. Equity Health"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12939-022-01704-6","article-title":"Judicialization of health: Profile of demands for oncological medicines in a state in the central region of Brazil","volume":"21","author":"Salha","year":"2022","journal-title":"Int. J. Equity Health"},{"key":"ref_71","first-page":"209","article-title":"J. The Judicialization of Health and the Quest for State Accountability: Evidence from 1262 Lawsuits for Access to Medicines in Southern Brazil","volume":"18","author":"Biehl","year":"2016","journal-title":"Health Hum. Rights"},{"key":"ref_72","unstructured":"Civil Society Engagement Mechanism (2024, December 11). Why the 2019 UN High-Level Meeting on Universal Health Coverage Should Encourage All Countries to Achieve This Target. Available online: https:\/\/csemonline.net\/wp-content\/uploads\/2019\/07\/WHY-5-of-GDP-1.pdf."},{"key":"ref_73","unstructured":"Our World in Data (2024, December 11). Government Health Expenditure as a Share of GDP, 1880 to 2021. Available online: https:\/\/ourworldindata.org\/grapher\/public-health-expenditure-share-gdp."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ijc.33407","article-title":"Progress, challenges and ways forward supporting cancer surveillance in Latin America","volume":"149","author":"Abriata","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_75","unstructured":"World Health Organization (2024, March 19). Health Inequality Monitor- About WHO\u2019s Work on Health Inequality Monitoring. Available online: https:\/\/www.who.int\/data\/inequality-monitor\/about."},{"key":"ref_76","unstructured":"Aday, L.A., Fleming, G.V., and Andersen, R. (1984). Access to Medical Care in the U.S.: Who Has It, Who Doesn\u2019t, Pluribus Press."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2190\/986L-LHQ6-2VTE-YRRN","article-title":"The Concepts and Principles of Equity and Health","volume":"22","author":"Whitehead","year":"1992","journal-title":"Int. J. Health Serv."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"151367","DOI":"10.1016\/j.apnr.2020.151367","article-title":"The concepts of health inequality, disparities and equity in the era of population health","volume":"56","author":"Lee","year":"2020","journal-title":"Appl. Nurs. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"27106","DOI":"10.3402\/gha.v8.27106","article-title":"Inequalities in health: Definitions, concepts, and theories","volume":"8","author":"Arcaya","year":"2015","journal-title":"Glob. Health Action"},{"key":"ref_80","unstructured":"Pan American Health Organization (1999). Methodological summaries: Measuring inequity in health. Epidemiol. Bull., 20, 11."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12939-019-1058-3","article-title":"The historical roots and seminal research on health equity: A referenced publication year spectroscopy (RPYS) analysis","volume":"18","author":"Yao","year":"2019","journal-title":"Int. J. Equity Health"},{"key":"ref_82","unstructured":"World Health Organization (2024, May 23). Constitution of the World Health Organization. Available online: https:\/\/www.who.int\/about\/governance\/constitution."},{"key":"ref_83","unstructured":"UN General Assembly (2024, July 20). Universal Declaration of Human Rights|United Nations. General Assembly Resolution. Available online: https:\/\/documents.un.org\/doc\/resolution\/gen\/nr0\/043\/88\/pdf\/nr004388.pdf."},{"key":"ref_84","unstructured":"World Health Organization (2024, May 17). Report of the International Conference on Primary Health Care, Alma-Ata, USSR, 6\u201312 September 1978. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/39228\/9241800011.pdf?sequence=1."},{"key":"ref_85","unstructured":"World Health Organization (2024, March 15). Health in 2015: From MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals. Available online: https:\/\/iris.who.int\/handle\/10665\/200009."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/237946151800400102","article-title":"What is Health Equity?","volume":"4","author":"Braveman","year":"2018","journal-title":"Behav. Sci. Policy"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e2133205","DOI":"10.1001\/jamanetworkopen.2021.33205","article-title":"Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies","volume":"4","author":"Aldrighetti","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tig.2020.07.001","article-title":"Equity in Health: Consideration of Race and Ethnicity in Precision Medicine","volume":"36","author":"Edwards","year":"2020","journal-title":"Trends Genet."},{"key":"ref_89","first-page":"1","article-title":"Planning for health equity in the Americas: An analysis of national health plans","volume":"45","author":"Kavanagh","year":"2021","journal-title":"Rev. Panam. Salud P\u00fablica"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12939-021-01426-1","article-title":"Understanding inequities in health and health systems in Latin America and the Caribbean: A thematic series","volume":"20","author":"Ruano","year":"2021","journal-title":"Int. J. Equity Health"},{"key":"ref_91","unstructured":"Centers for Disease Control and Prevention (2024, April 16). Equity in Cancer Prevention and Control, Available online: https:\/\/www.cdc.gov\/cancer\/health-equity\/equity.htm."},{"key":"ref_92","first-page":"e43445","article-title":"Addressing Cancer Disparities Through Community Engagement: Lessons and Best Practices","volume":"14","author":"Kale","year":"2023","journal-title":"Cureus"},{"key":"ref_93","unstructured":"National Cancer Institute (2024, April 16). Cancer Disparities, Available online: https:\/\/www.cancer.gov\/about-cancer\/understanding\/disparities."},{"key":"ref_94","unstructured":"World Health Organization (2024, June 13). Improving Service Access and Quality. Available online: https:\/\/www.who.int\/activities\/improving-service-access-and-quality."},{"key":"ref_95","unstructured":"World Health Organization (2024, June 13). Universal Health Coverage. Report by the Director-General. 154th Session. Available online: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB154\/B154_6-en.pdf."},{"key":"ref_96","unstructured":"World Health Organization (2024, August 16). Retention of the Health Workforce in Rural and Remote Areas: A Systematic Review. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/337300\/9789240013865-eng.pdf?sequence=1."},{"key":"ref_97","unstructured":"Thomas, S., Sagan, A., Larkin, J., Cylus, J., Figueiras, J., and Karanikolos, M. (2020). Strengthening Health Systems Resilience: Key Concepts and Strategies, European Observatory Policy Briefs."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2471\/BLT.16.187476","article-title":"Strengthening health systems for universal health coverage and sustainable development","volume":"95","author":"Kieny","year":"2017","journal-title":"Bull. World Health Organ."},{"key":"ref_99","unstructured":"World Health Organization (2024, June 12). Patient Engagement: Technical Series on Safer Primary Care. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/252269\/9789241511629-eng.pdf?sequence=1."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Handtke, O., Schilgen, B., and M\u00f6sko, M. (2019). Culturally competent healthcare\u2014A scoping review of strategies implemented in healthcare organizations and a model of culturally competent healthcare provision. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219971"},{"key":"ref_101","first-page":"e1400","article-title":"Recommendations for streamlining precision medicine in breast cancer care in Latin America","volume":"4","author":"Doimi","year":"2021","journal-title":"Cancer Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13690-022-00793-7","article-title":"Has Latin America achieved universal health coverage yet? Lessons from four countries","volume":"80","author":"Gilardino","year":"2022","journal-title":"Arch. Public Health"},{"key":"ref_103","unstructured":"Pan American Health Organization (2024, December 11). Universal Health- On the Road to Universal Health for Everyone, Everywhere. Available online: https:\/\/www.paho.org\/en\/universal-health."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2307\/20460103","article-title":"Judicial activism in the Argentine health system: Recent trends","volume":"10","author":"Abramovich","year":"2008","journal-title":"Health Hum. Rights"},{"key":"ref_105","first-page":"159","article-title":"The Right to Health as a Tool of Social Control: Compulsory Treatment Orders by Courts in Brazil","volume":"24","author":"Filho","year":"2022","journal-title":"Health Hum. Rights"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.healthpol.2003.10.004","article-title":"Universal health care for Colombians 10 years after Law 100: Challenges and opportunities","volume":"68","author":"Rosa","year":"2004","journal-title":"Health Policy"},{"key":"ref_107","unstructured":"Block, M.A.G., Morales, H.R., Hurtado, L.C., Balandr\u00e1n, A., and M\u00e9ndez, E. (2024, July 20). Mexico- Health System Review. Available online: https:\/\/iris.who.int\/handle\/10665\/334334."},{"key":"ref_108","unstructured":"Pan American Health Organization (2024, March 12). Health Systems Profile Panama: Monitoring and Analyzing Health Systems Change. Available online: https:\/\/www3.paho.org\/hq\/dmdocuments\/2010\/Health_System_Profile-Panama_2008.pdf."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1634\/theoncologist.2018-0318","article-title":"Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities","volume":"24","author":"Arai","year":"2019","journal-title":"Oncologist"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Sussman, L., Garcia-Robledo, J.E., Ord\u00f3\u00f1ez-Reyes, C., Forero, Y., and Mosquera, A.F. (2022). Ru\u00edz-Pati\u00f1o, A.; Chamorro, D.F.; Cardona, A.F. Integration of artificial intelligence and precision oncology in Latin America. Front. Med. Technol., 4.","DOI":"10.3389\/fmedt.2022.1007822"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The Concept of Access","volume":"19","author":"Penchansky","year":"1981","journal-title":"Med. Care"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Azeredo-da-Silva, A.F., Zanotto, B.S., Martins, F., Navarro, N., Alencar, R., and Medeiros, C. (2024). Health care accessibility and mobility in breast cancer: A Latin American perspective. BMC Health Serv. Res., 24.","DOI":"10.1186\/s12913-024-11222-6"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e100351","DOI":"10.1136\/bmjhci-2021-100351","article-title":"Telemammography for breast cancer screening: A cost-effective approach in Argentina","volume":"28","author":"Sun","year":"2021","journal-title":"BMJ Health Care Inform."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ol.2022.13233","article-title":"Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries (Review)","volume":"23","author":"Bogdanova","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.20.00642","article-title":"Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology","volume":"38","author":"Patel","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S2214-109X(18)30098-6","article-title":"Health equity, cancer, and social determinants of health","volume":"6","author":"Marmot","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"ref_117","unstructured":"National Human Genome Research Institute (2024, March 13). Precision Medicine, Available online: https:\/\/www.genome.gov\/genetics-glossary\/Precision-Medicine."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Nature Mental Health (2023). The right treatment for each patient: Unlocking the potential of personalized psychiatry. Nat. Ment. Health, 1, 607\u2013608.","DOI":"10.1038\/s44220-023-00131-y"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/AIA.0000000000000297","article-title":"Precision medicine in anesthesiology","volume":"58","author":"Jalilian","year":"2020","journal-title":"Int. Anesth. Clin."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Fernandes, B.S., Williams, L.M., Steiner, J., Leboyer, M., Carvalho, A.F., and Berk, M. (2017). The new field of \u2018precision psychiatry\u2019. BMC Med., 15.","DOI":"10.1186\/s12916-017-0849-x"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40291-017-0291-y","article-title":"Are the Origins of Precision Medicine Found in the Corpus Hippocraticum?","volume":"21","author":"Konstantinidou","year":"2017","journal-title":"Mol. Diagn. Ther."},{"key":"ref_122","unstructured":"Institute of Medicine (2001). Committee on Quality of Health Care in America. Crossing the Quality Chasm, National Academies Press."},{"key":"ref_123","unstructured":"Watanabe, J.H., Tarn, D.M., and Hirsch, J.D. (2021). Evolution of Precision Medicine: Applying a Population-Based Evidence Assessment Repository to Achieve Patient-Centered Outcomes at the Point of Care. Value Outcomes Spotlight, 7, Available online: https:\/\/www.ispor.org\/publications\/journals\/value-outcomes-spotlight\/vos-archives\/issue\/patients-versus-process-the-data-and-the-drivers-behind-patient-centered-outcomes."},{"key":"ref_124","unstructured":"National Human Genome Research Institute (2024, March 13). The Human Genome Project, Available online: https:\/\/www.genome.gov\/human-genome-project."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2013.09.006","article-title":"The Next-Generation Sequencing Revolution and Its Impact on Genomics","volume":"155","author":"Koboldt","year":"2013","journal-title":"Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7861\/clinmedicine.17-6-545","article-title":"The rise of the genome and personalised medicine","volume":"17","author":"Brittain","year":"2017","journal-title":"Clin. Med."},{"key":"ref_127","unstructured":"The White House (2024, March 21). President Obama\u2019s Precision Medicine Initiative, Available online: https:\/\/obamawhitehouse.archives.gov\/the-press-office\/2015\/01\/30\/fact-sheet-president-obama-s-precision-medicine-initiative."},{"key":"ref_128","unstructured":"US Food and Drug Administration (2024, March 13). Precision Medicine, Available online: https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/precision-medicine."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e1349","DOI":"10.1002\/hsr2.1349","article-title":"How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action","volume":"6","author":"Baird","year":"2023","journal-title":"Health Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13073-021-00886-y","article-title":"The impact of genomics on precision public health: Beyond the pandemic","volume":"13","author":"Khoury","year":"2021","journal-title":"Genome Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Tebani, A., Afonso, C., Marret, S., and Bekri, S. (2016). Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091555"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1310\/hpj5111-950","article-title":"Precision Medicine: Considerable Potential Combined with Important Challenges","volume":"51","author":"Fox","year":"2016","journal-title":"Hosp. Pharm."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"736","DOI":"10.15252\/embr.201438480","article-title":"Genes, the environment and personalized medicine","volume":"15","author":"Carlsten","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"McGrath, S., and Ghersi, D. (2016). Building towards precision medicine: Empowering medical professionals for the next revolution. BMC Med. Genom., 9.","DOI":"10.1186\/s12920-016-0183-8"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision Medicine, AI, and the Future of Personalized Health Care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Giordano, C., Brennan, M., Mohamed, B., Rashidi, P., Modave, F., and Tighe, P. (2021). Accessing Artificial Intelligence for Clinical Decision-Making. Front. Digit. Health, 25.","DOI":"10.3389\/fdgth.2021.645232"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Hassan, M., Awan, F.M., Naz, A., deAndr\u00e9s-Galiana, E.J., Alvarez, O., Cernea, A., Fern\u00e1ndez-Brillet, L., Fern\u00e1ndez-Mart\u00ednez, J.L., and Kloczkowski, A. (2022). Innovations in Genomics and Big Data Analytics for Personalized Medicine and Health Care: A Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094645"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/pme-2018-0120","article-title":"The Importance of Real-World Data to Precision Medicine","volume":"16","author":"Kalra","year":"2019","journal-title":"Per. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/MS9.0000000000000298","article-title":"Precision medicine and implications in medical education","volume":"85","author":"Lamichhane","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2217\/pme-2020-0049","article-title":"Personalized Medicine in Latin America","volume":"17","author":"Panduro","year":"2020","journal-title":"Per. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/joim.13698","article-title":"Implementation of precision medicine in healthcare\u2014A European perspective","volume":"294","author":"Stenzinger","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s43441-023-00565-7","article-title":"Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications","volume":"57","author":"Argotti","year":"2023","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1535370217733426","article-title":"Biomarkers and their impact on precision medicine","volume":"243","author":"Slikker","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"ref_144","unstructured":"World Health Organization (2024, March 13). International Programme on Chemical Safety Biomarkers and Risk Assessment: Concepts and Principles. Available online: www.inchem.org\/documents\/ehc\/ehc\/ehc155.htm."},{"key":"ref_145","unstructured":"Food and Drug Administration (2024, August 15). About Biomarkers and Qualification, Available online: https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/about-biomarkers-and-qualification."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.21037\/tlcr.2018.08.07","article-title":"Development of biomarkers for real precision medicine","volume":"7","author":"Shibata","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Perez, E.A. (2020). Biomarkers and Precision Medicine in Oncology Practice and Clinical Trials. Advancing the Science of Cancer in Latinos, Springer.","DOI":"10.1007\/978-3-030-29286-7_11"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Orsini, A., Diquigiovanni, C., and Bonora, E. (2023). Omics Technologies Improving Breast Cancer Research and Diagnostics. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612690"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Liao, J., Li, X., Gan, Y., Han, S., Rong, P., Wang, W., Li, W., and Zhou, L. (2023). Artificial intelligence assists precision medicine in cancer treatment. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.998222"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-21-0090","article-title":"Artificial Intelligence in Cancer Research and Precision Medicine","volume":"11","author":"Bhinder","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Stein, M.K., Oluoha, O., Patel, K., and VanderWalde, A. (2021). Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer. J. Pers. Med., 11.","DOI":"10.3390\/jpm11060518"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"The Lancet (2021). 20 years of precision medicine in oncology. Lancet, 397, 1781.","DOI":"10.1016\/S0140-6736(21)01099-0"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc.2016.56","article-title":"Biomarker development in the precision medicine era: Lung cancer as a case study","volume":"16","author":"Vargas","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_155","unstructured":"Personalized Medicine Coalition (2024, March 13). Personalized Medicine at FDA: A Progress & Outlook Report. Available online: https:\/\/www.personalizedmedicinecoalition.org\/Userfiles\/PMC-Corporate\/file\/PM_at_FDA_A_Progress_and_Outlook_Report.pdf."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccell.2020.03.014","article-title":"Toward a More Precise Future for Oncology","volume":"37","author":"Taylor","year":"2020","journal-title":"Cancer Cell."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: Evolution of the treatment paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Bhat, A.H., Khaja, U.M., Ahmed, M., Khan, W.Y., and Ganie, S.A. (2023). Pharmacogenomics in cancer. Pharmacogenomics, Elsevier.","DOI":"10.1016\/B978-0-443-15336-5.00001-4"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Drugan, T., and Leucu\u021ba, D. (2024). Evaluating Novel Biomarkers for Personalized Medicine. Diagnostics, 14.","DOI":"10.3390\/diagnostics14060587"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14737159.2022.2139602","article-title":"Predictive biomarkers and personalized pharmacotherapy","volume":"22","author":"Westergaard","year":"2022","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Das, S., Dey, M.K., Devireddy, R., and Gartia, M.R. (2023). Biomarkers in Cancer Detection, Diagnosis, and Prognosis. Sensors, 24.","DOI":"10.3390\/s24010037"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Sheng, K.L., Kang, L., Pridham, K.J., Dunkenberger, L.E., Sheng, Z., and Varghese, R.T. (2020). An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-78126-3"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Al-Tashi, Q., Saad, M.B., Muneer, A., Qureshi, R., Mirjalili, S., Sheshadri, A., Le, X., Vokes, N.I., Zhang, J., and Wu, J. (2023). Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097781"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Peng, S., Wang, H., Cai, X., and Wang, Q. (2024). Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products. Genes, 15.","DOI":"10.3390\/genes15040468"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/bib\/bbu039","article-title":"Deciphering oncogenic drivers: From single genes to integrated pathways","volume":"16","author":"Chen","year":"2015","journal-title":"Brief. Bioinform."},{"key":"ref_166","unstructured":"US Food and Drug Administration (2024, June 15). Table of Pharmacogenomic Biomarkers in Drug Labeling, Available online: https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/table-pharmacogenomic-biomarkers-drug-labeling."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"S842","DOI":"10.1016\/j.jtho.2021.08.759","article-title":"WS04.02 Access to Biomarker Testing in Latin America","volume":"16","author":"Dienstmann","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_169","first-page":"920","article-title":"Precision oncology in Latin America: Current situation, challenges and perspectives","volume":"13","author":"Orue","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"a036541","DOI":"10.1101\/cshperspect.a036541","article-title":"Cancer Genetic Counseling\u2014Current Practice and Future Challenges","volume":"10","author":"Schienda","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23808993.2018.1421858","article-title":"The economic case for precision medicine","volume":"3","author":"Gavan","year":"2018","journal-title":"Expert. Rev. Precis. Med. Drug Dev."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Quinn, R., Patel, R., Sison, C., Singh, A., and Zhu, X.H. (2021). Impact of Precision Medicine on Clinical Outcomes: A Single-Institution Retrospective Study. Front. Oncol., 31.","DOI":"10.3389\/fonc.2021.659113"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41698-024-00547-4","article-title":"Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)","volume":"8","author":"Anderson","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.18632\/oncotarget.24384","article-title":"Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs","volume":"9","author":"Haslem","year":"2018","journal-title":"Oncotarget"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-020-18613-3","article-title":"Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy","volume":"11","author":"Kato","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Song, I.W., Vo, H.H., Chen, Y.S., Baysal, M.A., Kahle, M., Johnson, A., and Tsimberidou, A.M. (2023). Precision Oncology: Evolving Clinical Trials across Tumor Types. Cancers, 15.","DOI":"10.3390\/cancers15071967"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Rulten, S.L., Grose, R.P., Gatz, S.A., Jones, J.L., and Cameron, A.J.M. (2023). The Future of Precision Oncology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612613"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.molmed.2017.08.003","article-title":"Precision Oncology: The Road Ahead","volume":"23","author":"Senft","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccell.2022.04.002","article-title":"The translational challenges of precision oncology","volume":"40","author":"Pich","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_181","unstructured":"National Cancer Institute (2024, March 20). Immune Checkpoint Inhibitor, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/immunotherapy\/checkpoint-inhibitors."},{"key":"ref_182","unstructured":"National Cancer Institute (2024, March 20). CAR T Cells: Engineering Patients\u2019 Immune Cells to Treat Their Cancers, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/research\/car-t-cells."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/omi.2010.0149","article-title":"Therapeutic Cancer Vaccines and Translating Vaccinomics Science to the Global Health Clinic: Emerging Applications Toward Proof of Concept","volume":"15","author":"Disis","year":"2011","journal-title":"OMICS"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Basharat, S., Smith, A., Darvesh, N., and Rader, T. (2023). Watch List: Top 10 Precision Medicine Technologies and Issues, Canadian Agency for Drugs and Technologies in Health.","DOI":"10.51731\/cjht.2022.590"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"103109","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: A broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10438599.2018.1549788","article-title":"What is the future of cancer care? A technology foresight assessment of experts\u2019 expectations","volume":"28","year":"2019","journal-title":"Econ. Innov. New Technol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Baxevanis, C.N. (2023). Biomarkers in the Era of Precision Oncology. Cancers, 15.","DOI":"10.3390\/cancers15061782"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12967-019-1864-9","article-title":"Are innovation and new technologies in precision medicine paving a new era in patients centric care?","volume":"17","author":"Seyhan","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-12-1627","article-title":"Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative","volume":"18","author":"Tsimberidou","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"56491","DOI":"10.18632\/oncotarget.10606","article-title":"Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers","volume":"7","author":"Radovich","year":"2016","journal-title":"Oncotarget"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/1535-7163.MCT-15-0795","article-title":"Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience","volume":"15","author":"Schwaederle","year":"2016","journal-title":"Mol. Cancer. Ther."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13073-016-0364-2","article-title":"Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: The Princess Margaret IMPACT\/COMPACT trial","volume":"8","author":"Stockley","year":"2016","journal-title":"Genome Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00038-019-01298-x","article-title":"Cost-effectiveness of precision medicine: A scoping review","volume":"64","author":"Kasztura","year":"2019","journal-title":"Int. J. Public Health"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/1878-0261.13038","article-title":"Cost-effectiveness of precision diagnostic testing for precision medicine approaches against non-small-cell lung cancer: A systematic review","volume":"15","author":"Henderson","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Meehan, J., Gray, M., Mart\u00ednez-P\u00e9rez, C., Kay, C., Pang, L.Y., Fraser, J., Poole, A.V., Kunkler, L.H., Langdon, S.P., and Argyle, D. (2020). Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00628"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2042098614560737","article-title":"Targeting precision medicine toxicity: Recent developments","volume":"6","author":"Mallarkey","year":"2015","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e434026","DOI":"10.1200\/EDBK_434026","article-title":"Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision Medicine","volume":"44","author":"Sedhom","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10728-017-0347-5","article-title":"Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?","volume":"27","author":"Sandman","year":"2019","journal-title":"Health Care Anal."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Sarhadi, V.K., and Armengol, G. (2022). Molecular Biomarkers in Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12081021"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/jcph.765","article-title":"Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment","volume":"56","author":"Schmidt","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"ref_203","unstructured":"National Cancer Institute (2024, April 15). Tumor Marker Tests in Common Use, Available online: https:\/\/www.cancer.gov\/about-cancer\/diagnosis-staging\/diagnosis\/tumor-markers-list."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e13731","DOI":"10.1200\/JCO.2024.42.16_suppl.e13731","article-title":"Sarcoma drug approvals in Latin America compared to the FDA and EMA: An analysis by the LACOG Sarcoma Group","volume":"42","author":"David","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_205","first-page":"100506","article-title":"Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: A retrospective analysis","volume":"22","author":"Marciniuk","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"ref_206","first-page":"13","article-title":"Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab","volume":"22","author":"Barrios","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1200\/GO.20.00081","article-title":"ABC4 Consensus: First Latin American Meeting\u2014Assessment, Comments, and Application of Its Recommendations","volume":"6","author":"Gomez","year":"2020","journal-title":"JCO Glob. Oncol."},{"key":"ref_208","unstructured":"World Health Organization (2024, June 20). National Cancer Control Programmes: Policies and Managerial Guidelines, Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/42494\/9241545577.pdf?sequence=1."},{"key":"ref_209","unstructured":"Pan American Health Organization (2024, March 01). Plan of Action for Cervical Cancer Prevention and Control 2018\u20132030. Washington, D.C. Available online: https:\/\/iris.paho.org\/handle\/10665.2\/38574."},{"key":"ref_210","unstructured":"Pan American Health Organization (2024, August 15). Breast Cancer: Knowledge Summaries for Health Professionals. Available online: https:\/\/www.paho.org\/en\/topics\/cancer\/breast-cancer-knowledge-summaries-health-professionals."},{"key":"ref_211","first-page":"e144","article-title":"Collaboration for success: The Global Initiative for Childhood Cancer in Latin America","volume":"47","author":"Ribeiro","year":"2023","journal-title":"Rev. Panam. Salud Publica"},{"key":"ref_212","unstructured":"Ministry of Health of Colombia (2024, February 18). MinSalud and Cancerology Institute Will Integrate Public Health and Cancer Control Plans. [Minsalud y Cancerologico Integraran Planes de Salud Public y Control de Cancer], Available online: https:\/\/www.minsalud.gov.co\/Paginas\/Minsalud-y-Cancerologico-integraran-planes-de-salud-publica-y-control-del-cancer.aspx."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S1470-2045(22)00057-2","article-title":"Equity in national cancer control plans in the region of the Americas","volume":"23","author":"Loggetto","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_214","unstructured":"Government Secretariat of Health\/National Cancer Institute (2024, February 26). Plan Nacional de Control de C\u00e1ncer 2018\u20132022 [National Cancer Control Plan 2018\u20132022]. Available online: https:\/\/www.iccp-portal.org\/resources\/plan-nacional-de-control-de-cancer-2018-2022."},{"key":"ref_215","unstructured":"Presidency of the Republic of Brazil (2024, February 11). Lei No. 14.758 de 19 de Dezembro de 2023. [Law No. 14,758 of 19 December 2023], Available online: https:\/\/www.in.gov.br\/en\/web\/dou\/-\/lei-n-14.758-de-19-de-dezembro-de-2023-532172581."},{"key":"ref_216","unstructured":"Presidency of the Republic of Brazil (2024, June 15). Lei No. 14.238, de 19 de Novembro de 2021, Available online: https:\/\/www.planalto.gov.br\/ccivil_03\/_Ato2019-2022\/2021\/Lei\/L14238.htm."},{"key":"ref_217","unstructured":"Presidency of the Republic of Brazil (2024, March 13). Lei No. 12.732, de 22 de Novembro de 2012, Available online: https:\/\/www.planalto.gov.br\/ccivil_03\/_ato2011-2014\/2012\/lei\/l12732.htm."},{"key":"ref_218","unstructured":"Presidency of Republic of Brazil (2024, May 15). Lei No. 12.715 de 17 de Setembro de 2012. [Law No. 12,715 of 17 September 2012], Available online: https:\/\/www.planalto.gov.br\/ccivil_03\/_ato2011-2014\/2012\/Lei\/L12715.htm."},{"key":"ref_219","unstructured":"Ministry of Health of Brazil (2024, February 18). Strategic Action Plan to Combat Chronic Diseases and Non-Communicable 2021\u20132030. [Plano de A\u00e7\u00f5es Estrat\u00e9gicas para o Enfrentamento das Doen\u00e7as Cr\u00f4nicas e Agravos n\u00e3o Transmiss\u00edveis no Brasil 2021\u20132030]. Available online: https:\/\/www.iccp-portal.org\/system\/files\/plans\/NCD%20plan%20Brazil%202021-2030.pdf."},{"key":"ref_220","unstructured":"Ministry of Health of Colombia (2024, February 18). 10-Year Cancer Control Plan 2012\u20132021, Available online: https:\/\/www.minsalud.gov.co\/Documents\/Plan-Decenal-Cancer\/PlanDecenal_ControlCancer_2012-2021.pdf."},{"key":"ref_221","unstructured":"Unified Regulatory Information System of Colombia (2024, March 18). Ley 1388 de 2010, Available online: https:\/\/www.suin-juriscol.gov.co\/viewDocument.asp?ruta=Leyes\/1678530."},{"key":"ref_222","unstructured":"Ministry of Health of Colombia (2024, February 18). Resolution No. 4496 of 2012, Available online: https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/Resolucion-4496-de-2012.PDF."},{"key":"ref_223","unstructured":"Congress of Colombia (2024, April 18). Law 1384 de 2010, Available online: https:\/\/www.funcionpublica.gov.co\/eva\/gestornormativo\/norma_pdf.php?i=39368."},{"key":"ref_224","unstructured":"Ministry of Social Protection (2024, February 18). Resolucion No. 0143, Available online: https:\/\/www.cancer.gov.co\/recursos_user\/Politicas\/Resoluci%C3%B3n_0143_de_2021_(2).pdf."},{"key":"ref_225","unstructured":"Ministry of Health of Mexico (2024, February 28). Programa de Acci\u00f3n Espec\u00edfico de Prevencion y Control del C\u00e1ncer 2021\u20132024 [Specific Action Program of Prevention and Control of Cancer 2021\u20132024.]. Available online: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/706943\/PAE_CAN_cF.pdf."},{"key":"ref_226","unstructured":"Ministry of Health of Mexico (2024, February 28). Ley General Para la Detecci\u00f3n Oportuna del C\u00e1ncer en la Infancia y la Adolescencia [General Law for the Timely Detection of Cancer in Childhood and Adolescence]. Available online: https:\/\/sidofqa.segob.gob.mx\/notas\/5609564."},{"key":"ref_227","unstructured":"Ministry of Health of Panama (2024, March 08). Plan Estrat\u00e9gico Nacional para la Prevenci\u00f3n y Control del C\u00e1ncer 2019\u20132029 [National Strategic Plan for Cancer Prevention and Control 2019\u20132029]. Available online: https:\/\/www.minsa.gob.pa\/sites\/default\/files\/publicaciones\/plan_estrategico_nacional_para_la_prevencion_y_control_del_cancer_2019_-_2029.pdf."},{"key":"ref_228","unstructured":"National Assembly of Panama (2024, March 12). Ley 154, de 13 de mayo de 2020 [Law 154, of 13 May 2020]. Available online: https:\/\/w3.css.gob.pa\/wp-content\/wdocs\/ASAMBLEA%20NACIONAL%20LEY%20154%20DEL%2013%20DE%20MAYO%20DE%202020.pdf."},{"key":"ref_229","unstructured":"Ministry of Health of Panama (2024, April 12). Decreto Ejecutivo No.382 de 4 de Septiembre de 2008. Available online: https:\/\/www.gacetaoficial.gob.pa\/pdfTemp\/26123\/13250.pdf."},{"key":"ref_230","unstructured":"Ministry of Health of Panama (2024, March 15). Resoluci\u00f3n No. 291 de 16 de Mayo de 2022. Available online: https:\/\/www.minsa.gob.pa\/sites\/default\/files\/normatividad\/resolucion_no_291_de_16_de_mayo_de_2022_normativa.pdf."},{"key":"ref_231","unstructured":"Secretariat of Planning and Policies in Science Technology and Innovation (2024, March 10). Poblar. Available online: https:\/\/www.argentina.gob.ar\/ciencia\/seppcti\/poblar."},{"key":"ref_232","unstructured":"Ministry of Health of Brazil (2024, February 12). Genomes Brasil, Available online: https:\/\/www.gov.br\/saude\/pt-br\/composicao\/sectics\/decit\/genomas-brasil."},{"key":"ref_233","unstructured":"Argentinian Government (2024, May 23). Mapa de Accionabilidad Gen\u00f3mica Tumoral Argentina (MAGenTa). Available online: https:\/\/www.argentina.gob.ar\/ciencia\/dnpe\/proyectos\/medicina-precision\/MAGenTa."},{"key":"ref_234","unstructured":"Argentinian Government (2024, May 23). Medicina de Precisi\u00f3n en C\u00e1ncer y Enfermedades poco Frecuentes (Epof-PAMPA). Available online: https:\/\/www.argentina.gob.ar\/ciencia\/dnpe\/proyectos\/medicina-precision\/epof-PAMPA."},{"key":"ref_235","unstructured":"Diario Oficial de la Federaci\u00f3n (2024, March 12). Ley General de Salud [General Health Law] (1984, February 7 rev. 2024, January 3). Available online: https:\/\/www.diputados.gob.mx\/LeyesBiblio\/pdf\/LGS.pdf."},{"key":"ref_236","unstructured":"Legislative Information System (2024, March 12). Iniciativa que Adiciona Diversas Disposiciones de la Ley General de Salud, en Materia de Medicina de Precisi\u00f3n, Suscrita por Diputados Integrantes del Grupo Parlamentario del Pan. Available online: http:\/\/sil.gobernacion.gob.mx\/Archivos\/Documentos\/2023\/04\/asun_4562318_20230426_1680209383.pdf."},{"key":"ref_237","unstructured":"Government of Argentina (2024, March 22). Poblar: Un Proyecto federal Para Que la Poblaci\u00f3n Argentina Cuente con un Biobanco Gen\u00f3mico propio. Available online: https:\/\/www.argentina.gob.ar\/noticias\/poblar-un-proyecto-federal-para-que-la-poblacion-argentina-cuente-con-un-biobanco-genomico."},{"key":"ref_238","unstructured":"Economist Impact (2024, August 15). The Journey Towards Health Improvement in Argentina: A Roadmap for Precision Medicine. Available online: https:\/\/impact.economist.com\/perspectives\/sites\/default\/files\/economist_impact_precision_medicine_argentina_english_v2.pdf."},{"key":"ref_239","unstructured":"Argentinian Government (2024, May 23). Biobanco Nacional de Muestras Biol\u00f3gicas: Una Herramienta Esencial Para el Desarrollo de Proyectos de Investigaci\u00f3n en el Campo de la Medicina de Precisi\u00f3n. Available online: https:\/\/www.argentina.gob.ar\/ciencia\/dnpe\/proyectos\/medicina-precision\/biobanco-nacional."},{"key":"ref_240","unstructured":"Argentinian Government (2024, May 23). Gen\u00f3mica cl\u00ednica de Enfermedades Pedi\u00e1tricas-GCEP. Available online: https:\/\/www.argentina.gob.ar\/ciencia\/dnpe\/proyectos\/medicina-precision\/enfermedades-pediatricas."},{"key":"ref_241","unstructured":"Centro de Estudios Regulatorios (2024, December 11). Dapre, Ley 2287 de 2023. Available online: https:\/\/www.cerlatam.com\/normatividad\/dapre-ley-2287-de-2023\/."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40487-023-00234-7","article-title":"Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011\u22122021","volume":"11","author":"Yan","year":"2023","journal-title":"Oncol. Ther."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.2217\/fon-2022-0540","article-title":"Trends in Real-World Biomarker Testing and Overall Survival in US Patients with Advanced Non-Small-Cell Lung Cancer","volume":"18","author":"Wu","year":"2022","journal-title":"Future Oncol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"e2100427","DOI":"10.1200\/PO.21.00427","article-title":"Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States","volume":"6","author":"Bruno","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"ref_245","unstructured":"Dieguez, G., and Carioto, J. (2024, August 15). The Landscape of Biomarker Testing Coverage in the United States. Available online: https:\/\/www.fightcancer.org\/sites\/default\/files\/the_landscape_of_biomarker_testing_coverage_in_the_u_s_0.pdf."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Norris, R.P., Dew, R., Sharp, L., Greystoke, A., Rice, S., Johnell, K., and Todd, A. (2020). Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis. BMC Med., 18.","DOI":"10.1186\/s12916-020-01753-0"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2022.09.005","article-title":"Access and quality of biomarker testing for precision oncology in Europe","volume":"176","author":"Normanno","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_248","unstructured":"EFPIA (2024, August 15). IQNPath. European Cancer Patient Coallition. Unlocking the Potential of Precision Medicine in Europe\u2014Improving Cancer Care Through Broader Access to Quality Biomarker Testing. Available online: https:\/\/www.efpia.eu\/media\/589673\/biomarker-testing-summary-final-version.pdf."},{"key":"ref_249","unstructured":"Memorial Sloan Kettering Cancer Center Library Precision Medicine: U.S (2024, August 15). Gov\u2019t Initiatives. Available online: https:\/\/libguides.mskcc.org\/precisionmedicine\/usgovt."},{"key":"ref_250","unstructured":"National Cancer Institute (2024, June 20). NCI-supported Precision Medicine Oncology Research Activities, Available online: https:\/\/dctd.cancer.gov\/MajorInitiatives\/NCI-supported_activities_in_precision_medicine.htm."},{"key":"ref_251","unstructured":"National Cancer Institute (2024, June 20). Center for Cancer Genomics. Supporting Genomic Science to Improve Cancer Diagnosis, Treatments, and Outcomes, Available online: https:\/\/www.cancer.gov\/ccg\/."},{"key":"ref_252","unstructured":"National Institutes of Health (2024, June 20). All of Us Research Program, Available online: https:\/\/allofus.nih.gov\/."},{"key":"ref_253","unstructured":"National Institutes of Health (2024, June 15). Transdisciplinary Collaborative Centers for Health Disparities Research Program, Available online: https:\/\/www.nimhd.nih.gov\/node\/22006."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/eurpub\/ckac103","article-title":"An overview of Personalized Medicine landscape and policies in the European Union","volume":"32","author":"Beccia","year":"2022","journal-title":"Eur. J. Public Health"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"e13868","DOI":"10.1111\/cts.13868","article-title":"Precision medicine in Asia enhanced by next-generation sequencing: Implications for Thailand through a scoping review and interview study","volume":"17","author":"Phanthunane","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41588-022-01274-x","article-title":"The Singapore National Precision Medicine Strategy","volume":"55","author":"Wong","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"860","DOI":"10.58631\/ajhs.v2i11.85","article-title":"Protection of Genetic Data in Health Services Based on Genomics Technology in Indonesia","volume":"2","author":"Susanti","year":"2023","journal-title":"Asian J. Healthy Sci."},{"key":"ref_258","unstructured":"Food and Drugs Administration (2024, July 04). Herceptin, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/103792s5250lbl.pdf."},{"key":"ref_259","unstructured":"European Medicines Agency (2024, July 04). Herceptin. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/herceptin."},{"key":"ref_260","unstructured":"Government of Mexico (2024, July 04). Consulta de Registros Sanitarios. Available online: https:\/\/tramiteselectronicos02.cofepris.gob.mx\/BuscadorPublicoRegistrosSanitarios\/BusquedaRegistroSanitario.aspx."},{"key":"ref_261","unstructured":"National Human Genome Research Institute (2024, July 04). NHGRI History and Timeline of Events, Available online: https:\/\/www.genome.gov\/about-nhgri\/Brief-History-Timeline."},{"key":"ref_262","unstructured":"Agencia Nacional de Vigilancia Sanitaria (2024, July 04). Herceptine, Available online: https:\/\/consultas.anvisa.gov.br\/#\/medicamentos\/8090?substancia=23119."},{"key":"ref_263","unstructured":"Food and Drugs Administration (2024, July 04). Gleevec, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021588s024lbl.pdf."},{"key":"ref_264","unstructured":"European Medicines Agency (2024, July 04). Glivec. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/glivec."},{"key":"ref_265","unstructured":"Agencia Nacional de Vigilancia Sanitaria (2024, July 04). Glivec, Available online: https:\/\/consultas.anvisa.gov.br\/#\/medicamentos\/5757?numeroRegistro=100680174."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMp1314561","article-title":"First FDA Authorization for Next-Generation Sequencer","volume":"369","author":"Collins","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_267","unstructured":"European Medicines Agency (2024, July 04). Keytruda. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/keytruda."},{"key":"ref_268","unstructured":"Food and Drugs Administration (2024, July 04). Food and Drugs Administration, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125514s066lbl.pdf."},{"key":"ref_269","unstructured":"International Consortium for Personalized Medicine (2024, July 04). ICPerMed. Available online: https:\/\/www.icpermed.eu\/."},{"key":"ref_270","unstructured":"European Commission (2024, July 04). Personalised Medicine. Available online: https:\/\/research-and-innovation.ec.europa.eu\/research-area\/health\/personalised-medicine_en."},{"key":"ref_271","unstructured":"Ministry of Human Rights and Citizenship (2024, July 04). Governo Federal Lan\u00e7a Programa In\u00e9dito de Medicina de Precis\u00e3o, Available online: https:\/\/www.gov.br\/mdh\/pt-br\/assuntos\/noticias\/2020-2\/outubro\/governo-federal-lanca-programa-inedito-de-medicina-de-precisao."},{"key":"ref_272","unstructured":"Agencia Nacional de Vigilancia Sanitaria (2024, July 04). Registrados Medicamentos Inovadores para C\u00e2ncer de Pele, Available online: https:\/\/antigo.anvisa.gov.br\/resultado-de-busca?p_p_id=101&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=column-1&p_p_col_count=1&_101_struts_action=%2Fasset_publisher%2Fview_content&_101_assetEntryId=3037244&_101_type=content&_101_groupId=219201&_101_urlTitle=registrados-medicamentos-inovadores-para-cancer-de-pele&inheritRedirect=true."},{"key":"ref_273","unstructured":"Genomics England (2024, July 04). 100,000 Genomes Project. Available online: https:\/\/www.genomicsengland.co.uk\/initiatives\/100000-genomes-project."},{"key":"ref_274","unstructured":"European Commission (2024, July 04). European \u201c1+ Million Genomes\u201d Initiative. Available online: https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/1-million-genomes."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Chong, H.Y., Allotey, P.A., and Chaiyakunapruk, N. (2018). Current landscape of personalized medicine adoption and implementation in Southeast Asia. BMC Med. Genom., 11.","DOI":"10.1186\/s12920-018-0420-4"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000502916","article-title":"Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives","volume":"22","author":"Chumnumwat","year":"2019","journal-title":"Public Health Genom."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tig.2014.11.004","article-title":"The H3Africa policy framework: Negotiating fairness in genomics","volume":"31","author":"Tindana","year":"2015","journal-title":"Trends Genet."},{"key":"ref_278","first-page":"59","article-title":"H3Africa: Current perspectives","volume":"11","author":"Mulder","year":"2018","journal-title":"Pharmgenomics Pers. Med."},{"key":"ref_279","unstructured":"NHS England (2024, July 08). NHS Genomic Medicine Service. Available online: https:\/\/www.england.nhs.uk\/genomics\/nhs-genomic-med-service\/."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Neuhaus, C.P., Pacia, D.M., Crane, J.T., Maschke, K.J., and Berlinger, N. (2023). All of Us and the Promise of Precision Medicine: Achieving Equitable Access for Federally Qualified Health Center Patients. J. Pers. Med., 13.","DOI":"10.3390\/jpm13040615"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjms.2015.10.012","article-title":"Achieving Equity in an Evolving Healthcare System: Opportunities and Challenges","volume":"351","author":"Williams","year":"2016","journal-title":"Am. J. Med. Sci."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Ory, M.G., Adepoju, O.E., Ramos, K.S., Silva, P.S., and Vollmer Dahlke, D. (2023). Health equity innovation in precision medicine: Current challenges and future directions. Front. Public Health, 15.","DOI":"10.3389\/fpubh.2023.1119736"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.7861\/fhj.2021-0063","article-title":"Patient and public understanding of the concept of \u2018personalised medicine\u2019 in relation to cancer treatment: A systematic review","volume":"8","author":"Botham","year":"2021","journal-title":"Future Health J."},{"key":"ref_284","first-page":"e49252","article-title":"Harnessing the Power of AI: A Comprehensive Review of Its Impact and Challenges in Nursing Science and Healthcare","volume":"22","author":"Yelne","year":"2023","journal-title":"Cureus"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"102498","DOI":"10.1016\/j.ctrv.2022.102498","article-title":"Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care","volume":"112","author":"Corti","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1530\/ERP-18-0081","article-title":"Application of mobile health, telemedicine and artificial intelligence to echocardiography","volume":"6","author":"Seetharam","year":"2019","journal-title":"Echo. Res. Pract."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1470-2045(13)70048-2","article-title":"Planning cancer control in Latin America and the Caribbean","volume":"14","author":"Goss","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/S1470-2045(16)30171-1","article-title":"Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing","volume":"17","author":"Ferreira","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_289","doi-asserted-by":"crossref","unstructured":"Fong, H., and Harris, E. (2015). Technology, innovation and health equity. Bull. World Health Organ., 93.","DOI":"10.2471\/BLT.15.155952"},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Gallifant, J., Nakayama, L.F., Gichoya, J.W., Pierce, R., and Celi, L.A. (2023). Equity should be fundamental to the emergence of innovation. PLoS Digit. Health, 2.","DOI":"10.1371\/journal.pdig.0000224"},{"key":"ref_291","first-page":"e00006122","article-title":"Current and future challenges of the use of precision medicine in cancer diagnosis and treatment in Brazil","volume":"38","author":"Santini","year":"2022","journal-title":"Cad. Saude Publica."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"e1359","DOI":"10.1002\/onco.13783","article-title":"Patients\u2019 and Oncologists\u2019 Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review","volume":"26","author":"Shirdarreh","year":"2021","journal-title":"Oncologist"},{"key":"ref_293","unstructured":"Dittrich, R. (2024, April 15). Healthcare Priority Setting in the Courts: A Reflection on Decision-Making When Healthcare Priority Setting Is Brought to Court. Available online: https:\/\/f1000research.com\/documents\/6-242."},{"key":"ref_294","first-page":"199","article-title":"El derecho a la salud en la jurisprudencia de la corte Interamericana De Derechos Humanos (2004\u20132014)","volume":"1","author":"Robles","year":"2016","journal-title":"Cuest. Constitucl."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.cllc.2016.05.003","article-title":"Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America","volume":"18","author":"Raez","year":"2017","journal-title":"Clin. Lung Cancer"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2018.02.014","article-title":"The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments","volume":"119","author":"Raez","year":"2018","journal-title":"Lung Cancer"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41576-021-00390-4","article-title":"Addressing health disparities in cancer with genomics","volume":"22","author":"Balogun","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision Medicine: From Science To Value","volume":"37","author":"Ginsburg","year":"2018","journal-title":"Health Aff."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13073-016-0362-4","article-title":"Integrating precision cancer medicine into healthcare\u2014Policy, practice, and research challenges","volume":"8","author":"Bertier","year":"2016","journal-title":"Genome Med."},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Lotsberg, M.L., and D\u2019mello Peters, S.A. (2022). Publication Bias in Precision Oncology and Cancer Biomarker Research. Challenges and Possible Implications, Cambridge University Press.","DOI":"10.1007\/978-3-030-92612-0_10"},{"key":"ref_301","doi-asserted-by":"crossref","unstructured":"Zavala, V.A., Serrano-Gomez, S.J., Dutil, J., and Fejerman, L. (2019). Genetic Epidemiology of Breast Cancer in Latin America. Genes, 10.","DOI":"10.3390\/genes10020153"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/538161a","article-title":"Genomics is failing on diversity","volume":"538","author":"Popejoy","year":"2016","journal-title":"Nature"},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Vargas, R.J., and Cobar, O.M. (2021). The Urgent Need for Management of Biological Samples and Data Accessibility in Latin America. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.620043"},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Cooke Bailey, J.N., Bush, W.S., and Crawford, D.C. (2020). Editorial: The Importance of Diversity in Precision Medicine Research. Front. Genet., 26.","DOI":"10.3389\/fgene.2020.00875"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/curroncol30010050","article-title":"Current Scenario of Clinical Cancer Research in Latin America and the Caribbean","volume":"30","author":"Rebelatto","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/joim.13709","article-title":"Precision cancer medicine: Concepts, current practice, and future developments","volume":"294","author":"Holmquist","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/23808993.2023.2292988","article-title":"The future of precision medicine in oncology","volume":"8","year":"2023","journal-title":"Expert. Rev. Precis. Med. Drug Dev."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Bestari, M.B., Joewono, I.R., and Syam, A.F. (2024). A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present. Biomolecules, 14.","DOI":"10.20944\/preprints202402.0955.v1"},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Lopez-Gonzalez, L., Sanchez Cendra, A., Sanchez Cendra, C., Roberts Cervantes, E.D., Espinosa, J.C., Pekarek, T., Fraile-Martinez, O., Garc\u00eda-Montero, C., and Rodriguez-Sloker, A.M. (2024). Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice. Medicina, 60.","DOI":"10.3390\/medicina60010168"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cpt.136","article-title":"Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization","volume":"98","author":"Amur","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.molonc.2014.10.004","article-title":"Biomarker validation and testing","volume":"9","author":"Hayes","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_312","first-page":"81","article-title":"Genetic Tests: Clinical Validity and Clinical Utility","volume":"24","author":"Burke","year":"2014","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"ref_313","unstructured":"National Cancer Institute (2024, June 15). Biomarker Testing for Cancer Treatment, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/biomarker-testing-cancer-treatment."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1200\/OP.23.00010","article-title":"Ferrying Oncologists Across the Chasm of Interpreting Biomarker Testing Reports: Systematic Support Needed to Improve Care and Decrease Disparities","volume":"19","author":"West","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.6004\/jadpro.2023.14.3.18","article-title":"The Advanced Practitioner\u2019s Role in the Rapidly Evolving Landscape of Precision Medicine","volume":"14","author":"Moore","year":"2023","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Al-Dewik, N.I., Younes, S.N., Essa, M.M., Pathak, S., and Qoronfleh, M.W. (2022). Making Biomarkers Relevant to Healthcare Innovation and Precision Medicine. Processes, 10.","DOI":"10.3390\/pr10061107"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/cts.13641","article-title":"Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020","volume":"16","author":"Bakker","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"S936","DOI":"10.21037\/tcr.2016.10.73","article-title":"Impact of social behavioral and genomic sciences on translational cancer research","volume":"5","author":"Tseng","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gde.2020.12.010","article-title":"Challenges of diagnostic genomics in Latin America","volume":"66","year":"2021","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40258-021-00670-4","article-title":"Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America","volume":"20","author":"Vogler","year":"2022","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1017\/S0266462315000094","article-title":"Implications of global pricing policies on access to innovative drugs: The case of trastuzumab in seven Latin American countries","volume":"31","author":"Garay","year":"2015","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"ref_322","unstructured":"UNESCO (2024, December 11). Fact Sheet No. 59-Global Investments in R&D. Available online: https:\/\/uis.unesco.org\/sites\/default\/files\/documents\/fs59-global-investments-rd-2020-en.pdf."},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"The Lancet Oncology (2018). Violence, crime, corruption, and cuts in public spending: How to re-establish cancer control in Latin America?. Lancet Oncol., 19, 1417.","DOI":"10.1016\/S1470-2045(18)30777-0"},{"key":"ref_324","unstructured":"FIFARMA & IQVIA (2024, March 11). Patient WAIT Indicator 2023\u2014Latin America: Final Report. Available online: https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/IQVIA-FIFARMA_WAIT-Indicator-2023_FinalPresentation_5Mar24_vS.pdf."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vhri.2019.10.002","article-title":"Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America","volume":"23","author":"Gilardino","year":"2020","journal-title":"Value Health Reg. Issues"},{"key":"ref_326","first-page":"e165","article-title":"Strengthening and implementing health technology assessment and the decision-making process in the Region of the Americas","volume":"41","author":"Lessa","year":"2017","journal-title":"Rev. Panam. Salud. P\u00fablica"},{"key":"ref_327","unstructured":"World Health Organization (2024). Guidance for Human Genome Data Collection, Access, Use and Sharing, The World Health Organization."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/8\/1220\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:23:40Z","timestamp":1760034220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/8\/1220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":327,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijerph22081220"],"URL":"https:\/\/doi.org\/10.3390\/ijerph22081220","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}